Crossref
Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy
Ain Shams Medical Journal · 2013
DOI: 10.12816/0013822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ain Shams Medical Journal, 2013. Verfasst von Mohsen M. Maher und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Maher, M. M., Hetta, O. M., Ibrahim, W. A., & El-Ghandour, A. M. (2013). Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy. Ain Shams Medical Journal. https://doi.org/10.12816/0013822
Vancouver
Maher MM, Hetta OM, Ibrahim WA, El-Ghandour AM. Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy. Ain Shams Medical Journal. 2013. doi:10.12816/0013822
BibTeX
@article{Maher2013,
author = {Maher, Mohsen M. and Hetta, Osama M. and Ibrahim, Wesam A. and El-Ghandour, Ahmed M.},
title = {Assessment of PIVKA II as a Marker in Recurrent Hepatocellular Carcinoma after Radiofrequency Ablation Therapy},
journal = {Ain Shams Medical Journal},
year = {2013},
doi = {10.12816/0013822}
}
EUVIMED